-
Je něco špatně v tomto záznamu ?
Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections
Z. Ježíková, T. Pagáč, B. Pfeiferová, H. Bujdáková, S. Dižová, I. Jančíková, D. Gášková, P. Olejníková,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 1997-02-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2011-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do 2017-12-31
- MeSH
- ABC transportéry antagonisté a inhibitory genetika MeSH
- antifungální látky chemická syntéza farmakologie terapeutické užití MeSH
- Candida albicans účinky léků genetika MeSH
- dihydropyridiny chemická syntéza farmakologie terapeutické užití MeSH
- flukonazol farmakologie terapeutické užití MeSH
- fungální léková rezistence účinky léků MeSH
- fungální proteiny antagonisté a inhibitory genetika MeSH
- kandidóza farmakoterapie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mutace MeSH
- regulace genové exprese u hub účinky léků MeSH
- sterol-14-demethylasa genetika MeSH
- synergismus léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
With emerging fungal infections and developing resistance, there is a need for understanding the mechanisms of resistance as well as its clinical impact while planning the treatment strategies. Several approaches could be taken to overcome the problems arising from the management of fungal diseases. Besides the discovery of novel effective agents, one realistic alternative is to enhance the activity of existing agents. This strategy could be achieved by combining existing antifungal agents with other bioactive substances with known activity profiles (combination therapy). Azole antifungals are the most frequently used class of substances used to treat fungal infections. Fluconazole is often the first choice for antifungal treatment. The aim of this work was to study potential synergy between azoles and 1,4-dihydropyridine-2,3,5-tricarboxylate (termed derivative H) in order to control fungal infections. This article points out the synergy between azoles and newly synthesized derivative H in order to fight fungal infections. Experiments confirmed the role of derivative H as substrate/inhibitor of fungal transporter Cdr1p relating to increased sensitivity to fluconazole. These findings, plus decreased expression of ERG11, are responsible for the synergistic effect.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033873
- 003
- CZ-PrNML
- 005
- 20250325103504.0
- 007
- ta
- 008
- 181008s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10482-017-0895-6 $2 doi
- 035 __
- $a (PubMed)28593476
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Ježíková, Zuzana $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37, Bratislava, Slovakia. zuz.jezikova@gmail.com.
- 245 10
- $a Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections / $c Z. Ježíková, T. Pagáč, B. Pfeiferová, H. Bujdáková, S. Dižová, I. Jančíková, D. Gášková, P. Olejníková,
- 520 9_
- $a With emerging fungal infections and developing resistance, there is a need for understanding the mechanisms of resistance as well as its clinical impact while planning the treatment strategies. Several approaches could be taken to overcome the problems arising from the management of fungal diseases. Besides the discovery of novel effective agents, one realistic alternative is to enhance the activity of existing agents. This strategy could be achieved by combining existing antifungal agents with other bioactive substances with known activity profiles (combination therapy). Azole antifungals are the most frequently used class of substances used to treat fungal infections. Fluconazole is often the first choice for antifungal treatment. The aim of this work was to study potential synergy between azoles and 1,4-dihydropyridine-2,3,5-tricarboxylate (termed derivative H) in order to control fungal infections. This article points out the synergy between azoles and newly synthesized derivative H in order to fight fungal infections. Experiments confirmed the role of derivative H as substrate/inhibitor of fungal transporter Cdr1p relating to increased sensitivity to fluconazole. These findings, plus decreased expression of ERG11, are responsible for the synergistic effect.
- 650 _2
- $a ABC transportéry $x antagonisté a inhibitory $x genetika $7 D018528
- 650 _2
- $a antifungální látky $x chemická syntéza $x farmakologie $x terapeutické užití $7 D000935
- 650 _2
- $a Candida albicans $x účinky léků $x genetika $7 D002176
- 650 _2
- $a kandidóza $x farmakoterapie $7 D002177
- 650 _2
- $a dihydropyridiny $x chemická syntéza $x farmakologie $x terapeutické užití $7 D004095
- 650 _2
- $a fungální léková rezistence $x účinky léků $7 D025141
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a flukonazol $x farmakologie $x terapeutické užití $7 D015725
- 650 _2
- $a fungální proteiny $x antagonisté a inhibitory $x genetika $7 D005656
- 650 _2
- $a regulace genové exprese u hub $x účinky léků $7 D015966
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a sterol-14-demethylasa $x genetika $7 D058886
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pagáč, Tomáš $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37, Bratislava, Slovakia.
- 700 1_
- $a Pfeiferová, Barbora $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37, Bratislava, Slovakia.
- 700 1_
- $a Bujdáková, Helena, $d 1964- $u Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University, Mlynská dolina, Ilkovičova 6, 842 15, Bratislava 4, Slovakia. $7 xx0330305
- 700 1_
- $a Dižová, Stanislava $u Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University, Mlynská dolina, Ilkovičova 6, 842 15, Bratislava 4, Slovakia.
- 700 1_
- $a Jančíková, Iva $u Institute of Physics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 3, 121 16, Praha 2, Czech Republic.
- 700 1_
- $a Gášková, Dana $u Institute of Physics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 3, 121 16, Praha 2, Czech Republic.
- 700 1_
- $a Olejníková, Petra $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37, Bratislava, Slovakia.
- 773 0_
- $w MED00000481 $t Antonie van Leeuwenhoek $x 1572-9699 $g Roč. 110, č. 9 (2017), s. 1219-1226
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28593476 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20250325103505 $b ABA008
- 999 __
- $a ok $b bmc $g 1339632 $s 1030867
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 110 $c 9 $d 1219-1226 $e 20170607 $i 1572-9699 $m Antonie van Leeuwenhoek $n Antonie Van Leeuwenhoek $x MED00000481
- LZP __
- $a Pubmed-20181008
